Gilead Sciences, Inc. (GILD) CEO Dan O'Day Presents at 38th Annual J.P. Morgan Healthcare Conference (Transcript)

Jan. 13, 2020 3:50 PM ETGilead Sciences, Inc. (GILD)15 Comments
SA Transcripts profile picture
SA Transcripts

Gilead Sciences, Inc. (NASDAQ:GILD) 38th Annual J.P. Morgan Healthcare Conference Call January 13, 2019 12:30 PM ET

Company Participants

Daniel O'Day - Chairman & Chief Executive Officer

Conference Call Participants

Cory Kasimov - J.P. Morgan

Cory Kasimov

All right. Good morning, everyone. My name is Cory Kasimov. I’m the senior large-cap biotech analyst at J.P. Morgan. And it is my pleasure to introduce our next company Gilead Sciences and making his first presentation at the J.P. Morgan Healthcare Conference is new Chairman and CEO Dan O'Day. Please note that following Dan's presentation, there will be a breakout just down the hall in the Georgian -- in the Borge room. So good luck getting back there. With that, I will turn it over to Dan.

Daniel O'Day

Thank you very much, Cory. Good morning, everybody. It's terrific to be here first time with Gilead. I’ve been here before obviously. I'd like to just say I'm really excited to walk through the next chapter with you. As we turn this decade, the reasons that I came to Gilead have only been amplified over the past 10 months, and that is when you think back to the medical breakthroughs that occurred over the past decade and most of the published reports that come out at the end of the year, it's astonishing and quite -- in fact quite extraordinary to see that two of the top 10 came from this company, Gilead; the ability to cure hepatitis C and the ability to turn HIV from a death sentence to a chronic preventable illness. And it's that type of -- a lot of people talk about keeping the bar high, but it's -- that's what we mean at Gilead when we say keeping the bar high for next generations of innovation.

I’m conscious of

Recommended For You

Comments (15)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.